Levent Tabak

475 total citations
24 papers, 263 citations indexed

About

Levent Tabak is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Hematology. According to data from OpenAlex, Levent Tabak has authored 24 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 4 papers in Hematology. Recurrent topics in Levent Tabak's work include Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Levent Tabak is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Levent Tabak collaborates with scholars based in Türkiye, Sweden and Norway. Levent Tabak's co-authors include Zeki Kılıçaslan, Çağlar Çuhadaroğlu, Mustafa Erelel, Dilek Yılmazbayhan, Ulrich Costabel, Feyza Erkan, Esen Kıyan, Gerhard Hoheisel, Helmut Teschler and Gülfer Okumuş and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Respiratory Medicine.

In The Last Decade

Levent Tabak

22 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levent Tabak Türkiye 9 101 67 66 55 38 24 263
Wongi Woo South Korea 9 78 0.8× 76 1.1× 11 0.2× 34 0.6× 46 1.2× 45 288
Valentina De Zan Italy 8 194 1.9× 14 0.2× 40 0.6× 21 0.4× 72 1.9× 8 310
Neeraj Desai United States 9 49 0.5× 139 2.1× 62 0.9× 9 0.2× 35 0.9× 29 263
Nira Arad‐Cohen Israel 9 25 0.2× 63 0.9× 43 0.7× 22 0.4× 11 0.3× 26 236
Osama Mukhtar United States 8 95 0.9× 27 0.4× 65 1.0× 12 0.2× 75 2.0× 48 260
Agnès Suc France 10 60 0.6× 34 0.5× 81 1.2× 12 0.2× 49 1.3× 33 284
Mirela Loredana Grigoraş Romania 11 87 0.9× 61 0.9× 53 0.8× 12 0.2× 54 1.4× 41 304
Manish Joshi United States 10 93 0.9× 72 1.1× 184 2.8× 10 0.2× 60 1.6× 34 325
Helen Stevens United Kingdom 7 86 0.9× 57 0.9× 99 1.5× 20 0.4× 24 0.6× 12 271
Jaivinder Yadav India 10 91 0.9× 25 0.4× 34 0.5× 18 0.3× 25 0.7× 61 315

Countries citing papers authored by Levent Tabak

Since Specialization
Citations

This map shows the geographic impact of Levent Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Tabak more than expected).

Fields of papers citing papers by Levent Tabak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levent Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Tabak. The network helps show where Levent Tabak may publish in the future.

Co-authorship network of co-authors of Levent Tabak

This figure shows the co-authorship network connecting the top 25 collaborators of Levent Tabak. A scholar is included among the top collaborators of Levent Tabak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levent Tabak. Levent Tabak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peker, Yüksel, Baran Balcan, Levent Tabak, et al.. (2021). Effect of High-Risk Obstructive Sleep Apnea on Clinical Outcomes in Adults with Coronavirus Disease 2019: A Multicenter, Prospective, Observational Clinical Trial. Annals of the American Thoracic Society. 18(9). 1548–1559. 29 indexed citations
2.
Keske, Şiran, Süda Tekin, Mahir Kapmaz, et al.. (2020). Appropriate use of tocilizumab in COVID-19 infection. International Journal of Infectious Diseases. 99. 338–343. 35 indexed citations
3.
Keske, Şiran, Levent Tabak, Nahit Çakar, et al.. (2020). Bortezomib induced pulmonary toxicity: a case report and review of the literature. PubMed. 10(6). 407–415. 4 indexed citations
4.
Özyiğit, Leyla Pur, Esin Aktaş Çetin, Ayşe Bilge Öztürk, et al.. (2019). The role of atopy in the pathogenesis of bleomycin pulmonary toxicity. Respiratory Medicine. 155. 1–5. 3 indexed citations
5.
Öztürk, Ayşe Bilge, et al.. (2018). Reporting Adverse Drug Reactions in a Tertiary Care Hospital in Istanbul. Turkish Thoracic Journal. 19(4). 237–239. 1 indexed citations
6.
Acar, Ömer, Yeşim Sağlıcan, Alan A. Sag, et al.. (2016). Isolated omental metastasis of renal cell carcinoma after extraperitoneal open partial nephrectomy: A case report. International Journal of Surgery Case Reports. 21. 6–11. 5 indexed citations
7.
Öztürk, Ayşe Bilge, Leyla Pur Özyiğit, Suat Erus, et al.. (2015). A case of uncontrolled severe asthma patient with coexisting carcinoid tumor presenting as pneumomediastinum. Journal of Asthma. 52(10). 1095–1098. 2 indexed citations
8.
Yakar, Fatih, et al.. (2014). Use of PET-CT for the assessment of treatment results in patients with sarcoidosis. Wiener klinische Wochenschrift. 127(7-8). 274–282. 4 indexed citations
9.
Tomruk, Ceyda Özçakır, Hakkı Tanyeri, Levent Tabak, & Öner Doğan. (2011). The Value of Labial Biopsy in the Differential Diagnosis of Sarcoidosis and Sjögren's Sydrome and Immunohistochemical Analysis. Biotechnology & Biotechnological Equipment. 25(2). 2399–2404. 1 indexed citations
10.
Okumuş, Gülfer, et al.. (2009). Comparison of three clinical scoring methods in patients with pulmonary thromboembolism.. PubMed. 57(2). 163–8. 1 indexed citations
11.
Okumuş, Gülfer, Esen Kıyan, Levent Tabak, et al.. (2007). Hereditary Thrombophilic Risk Factors and Venous Thromboembolism in Istanbul, Turkey: The Role in Different Clinical Manifestations of Venous Thromboembolism. Clinical and Applied Thrombosis/Hemostasis. 14(2). 168–173. 22 indexed citations
12.
Okumuş, Gülfer, Esen Kıyan, Levent Tabak, et al.. (2007). Platelet Glycoprotein Ia 807c/T and 873g/A Polymorphisms in Patients With Venous Thromboembolism. Clinical and Applied Thrombosis/Hemostasis. 13(1). 101–103. 5 indexed citations
13.
Artım-Esen, Bahar, Esen Kıyan, Reyhan Diz Küçükkaya, et al.. (2005). Antiphospholipid Syndrome Presenting As Massive Pulmonary Embolism in a Patient With Sarcoidosis. Electronic Journal of General Medicine. 2(4). 173–176. 4 indexed citations
14.
Okumuş, Gülfer, et al.. (2004). INHERITED THROMBOPHILIC RISK FACTORS IN VENOUSTHROMBOEMBOLISM: FACTOR V LEIDEN AND PROTHROMBIN 20210 A. 5(2). 82–85. 2 indexed citations
15.
Çuhadaroğlu, Çağlar, Mustafa Erelel, Levent Tabak, & Zeki Kılıçaslan. (2002). Increased risk of tuberculosis in health care workers: a retrospective survey at a teaching hospital in Istanbul, Turkey. BMC Infectious Diseases. 2(1). 14–14. 48 indexed citations
16.
Kıyan, Esen, et al.. (2002). An unusual radiographic finding in pulmonary parenchymal endometriosis: A case report. Acta Radiologica. 43(2). 164–166. 10 indexed citations
17.
Kıyan, Esen, et al.. (2002). An unusual radiographic finding in pulmonary parenchymal endometriosis. A case report. Acta Radiologica. 43(2). 164–166. 12 indexed citations
18.
Hoheisel, Gerhard, et al.. (1994). Bronchoalveolar Lavage Cytology and Immunocytology in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 149(2). 460–463. 47 indexed citations
19.
Tabak, Levent, et al.. (1994). Value of bronchoalveolar lavage in lipidoses with pulmonary involvement. European Respiratory Journal. 7(2). 409–411. 17 indexed citations
20.
Kaymakoğlu, Sabahattin, et al.. (1992). Karaciğer Sirozunda Hipoksemi. 3(1). 37–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wongi Woo Breakdown of academic impact, for papers by Valentina De Zan Breakdown of academic impact, for papers by Neeraj Desai Breakdown of academic impact, for papers by Nira Arad‐Cohen Breakdown of academic impact, for papers by Osama Mukhtar Breakdown of academic impact, for papers by Agnès Suc Breakdown of academic impact, for papers by Mirela Loredana Grigoraş Breakdown of academic impact, for papers by Manish Joshi Breakdown of academic impact, for papers by Helen Stevens Breakdown of academic impact, for papers by Jaivinder Yadav
Rankless by CCL
2026